[
  {
    "ts": null,
    "headline": "Tariff deadline, jobs report, Exxon earnings: What to Watch",
    "summary": "Market Domination Overtime host Josh Lipton takes a look at the top stories for investors to watch on Friday, Aug. 1. Friday is President Trump's self-imposed trade deal deadline. A host of trade deals was announced on Thursday, while markets wait to hear more. The July jobs report will be released in the morning. Economists are expecting a decrease in nonfarm payrolls and a slight uptick in both unemployment and hourly wages. Exxon (XOM), Chevron (CVX), Moderna (MRNA), and more will be posting quarterly earnings results in the morning. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
    "url": "https://finnhub.io/api/news?id=9f1a22c99dfbdcfa5b079525a29496b22742e43a17bb1a15cc71a7cf28f89206",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754000100,
      "headline": "Tariff deadline, jobs report, Exxon earnings: What to Watch",
      "id": 136160882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Market Domination Overtime host Josh Lipton takes a look at the top stories for investors to watch on Friday, Aug. 1. Friday is President Trump's self-imposed trade deal deadline. A host of trade deals was announced on Thursday, while markets wait to hear more. The July jobs report will be released in the morning. Economists are expecting a decrease in nonfarm payrolls and a slight uptick in both unemployment and hourly wages. Exxon (XOM), Chevron (CVX), Moderna (MRNA), and more will be posting quarterly earnings results in the morning. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
      "url": "https://finnhub.io/api/news?id=9f1a22c99dfbdcfa5b079525a29496b22742e43a17bb1a15cc71a7cf28f89206"
    }
  },
  {
    "ts": null,
    "headline": "Moderna plans to slash 10% of workforce as COVID shot sales slow",
    "summary": "Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.",
    "url": "https://finnhub.io/api/news?id=473ac73ce2c416a79030d0fb716ddd7fcabe1e2cbafd8d625045f009eac29340",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753998466,
      "headline": "Moderna plans to slash 10% of workforce as COVID shot sales slow",
      "id": 136161638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.",
      "url": "https://finnhub.io/api/news?id=473ac73ce2c416a79030d0fb716ddd7fcabe1e2cbafd8d625045f009eac29340"
    }
  },
  {
    "ts": null,
    "headline": "Franklin Biotechnology Discovery Fund Q2 2025 Commentary",
    "summary": "Franklin Templetonâs Biotechnology Discovery Fund sees long-term potential despite Q2 losses. Explore how innovation and AI are shaping its outlook.",
    "url": "https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753997700,
      "headline": "Franklin Biotechnology Discovery Fund Q2 2025 Commentary",
      "id": 136159393,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1408826216/image_1408826216.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Franklin Templetonâs Biotechnology Discovery Fund sees long-term potential despite Q2 losses. Explore how innovation and AI are shaping its outlook.",
      "url": "https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to Report Earnings Amid Shrinking Cash Balance. Investors Want to See If It Can Stop the Bleeding.",
    "summary": "Moderna  is due to report its second-quarter financial results on Friday ahead of the market open, a day after announcing plans to cut 10% of its staff as the company’s cash hoard continues to shrink.  Moderna’s second-quarter performance is largely beside the point.  Instead, investors are focused on the big question looming over the stock: Can Moderna stop losing money before it runs out of cash?",
    "url": "https://finnhub.io/api/news?id=6f417f171f137d443cab0132df0ec4616a510db1ba7f981096820c8db912f9f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753995060,
      "headline": "Moderna to Report Earnings Amid Shrinking Cash Balance. Investors Want to See If It Can Stop the Bleeding.",
      "id": 136161640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna  is due to report its second-quarter financial results on Friday ahead of the market open, a day after announcing plans to cut 10% of its staff as the company’s cash hoard continues to shrink.  Moderna’s second-quarter performance is largely beside the point.  Instead, investors are focused on the big question looming over the stock: Can Moderna stop losing money before it runs out of cash?",
      "url": "https://finnhub.io/api/news?id=6f417f171f137d443cab0132df0ec4616a510db1ba7f981096820c8db912f9f4"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Fall Late Afternoon",
    "summary": "Health care stocks fell late Thursday afternoon, with the NYSE Health Care Index declining 2% and th",
    "url": "https://finnhub.io/api/news?id=cc3fac7f2a3bf3393f948926a780b3ce8edcb8ca0ce6655fad02581f260210b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753991782,
      "headline": "Sector Update: Health Care Stocks Fall Late Afternoon",
      "id": 136160931,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks fell late Thursday afternoon, with the NYSE Health Care Index declining 2% and th",
      "url": "https://finnhub.io/api/news?id=cc3fac7f2a3bf3393f948926a780b3ce8edcb8ca0ce6655fad02581f260210b3"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "0815 GMT – Sanofi’s higher costs overshadow an upgrade to its full-year guidance, Intron Health’s Naresh Chouhan and Dominic Rose say in a research note.  Sales at the French pharmaceutical company beat expectations, but its earnings came in weaker than expected due to higher costs and currency headwinds, Intron says.  Sanofi’s business operating profit missed consensus expectations by 4%, Intron says.",
    "url": "https://finnhub.io/api/news?id=ff6003e01792e240f8199134174e4341dca62ed2b7c045560fbe3581c9a4ee64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753966860,
      "headline": "Health Care Roundup: Market Talk",
      "id": 136154426,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "0815 GMT – Sanofi’s higher costs overshadow an upgrade to its full-year guidance, Intron Health’s Naresh Chouhan and Dominic Rose say in a research note.  Sales at the French pharmaceutical company beat expectations, but its earnings came in weaker than expected due to higher costs and currency headwinds, Intron says.  Sanofi’s business operating profit missed consensus expectations by 4%, Intron says.",
      "url": "https://finnhub.io/api/news?id=ff6003e01792e240f8199134174e4341dca62ed2b7c045560fbe3581c9a4ee64"
    }
  },
  {
    "ts": null,
    "headline": "Nvidia, eBay, Moderna: Trending Tickers",
    "summary": "Nvidia (NVDA) is in focus after Chinese regulators flagged security concerns in its H20 AI chips. eBay (EBAY) stock is jumping after the company issued a strong sales forecast, driven by increased demand for used and refurbished goods. Moderna (MRNA) is cutting 10% of its global workforce as it reins in costs amid falling COVID-19 vaccine sales. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=4a3236cf1110dbfe344bc343a13b0a850945f2a370a23eb8ed6c94578af985df",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753974381,
      "headline": "Nvidia, eBay, Moderna: Trending Tickers",
      "id": 136154966,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Nvidia (NVDA) is in focus after Chinese regulators flagged security concerns in its H20 AI chips. eBay (EBAY) stock is jumping after the company issued a strong sales forecast, driven by increased demand for used and refurbished goods. Moderna (MRNA) is cutting 10% of its global workforce as it reins in costs amid falling COVID-19 vaccine sales. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=4a3236cf1110dbfe344bc343a13b0a850945f2a370a23eb8ed6c94578af985df"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to lay off 10% of workforce in ‘difficult but necessary step’",
    "summary": "In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the “realities of our business.”",
    "url": "https://finnhub.io/api/news?id=10eafd7e8013d568f3498e01658654f2e07ccad9623cc4c997ea964c94348d7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753961220,
      "headline": "Moderna to lay off 10% of workforce in ‘difficult but necessary step’",
      "id": 136155695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the “realities of our business.”",
      "url": "https://finnhub.io/api/news?id=10eafd7e8013d568f3498e01658654f2e07ccad9623cc4c997ea964c94348d7e"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Cuts 10% of Its Staff as Cash Hoard Dwindles",
    "summary": "The layoffs come as Moderna’s cash position has raised worries on Wall Street that the company may need to raise new capital.",
    "url": "https://finnhub.io/api/news?id=430324bc38542fd6289b81fdb9e22ebc51c2171afd08fadf3bbd853e53a776e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753960500,
      "headline": "Moderna Cuts 10% of Its Staff as Cash Hoard Dwindles",
      "id": 136152275,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The layoffs come as Moderna’s cash position has raised worries on Wall Street that the company may need to raise new capital.",
      "url": "https://finnhub.io/api/news?id=430324bc38542fd6289b81fdb9e22ebc51c2171afd08fadf3bbd853e53a776e6"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Earnings: What To Look For From MRNA",
    "summary": "Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.",
    "url": "https://finnhub.io/api/news?id=f9dc336c8b6c09ac083772211c983f37d9e03bfdc77e02c48a0e69bfab012479",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753930850,
      "headline": "Moderna Earnings: What To Look For From MRNA",
      "id": 136149975,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.",
      "url": "https://finnhub.io/api/news?id=f9dc336c8b6c09ac083772211c983f37d9e03bfdc77e02c48a0e69bfab012479"
    }
  }
]